Daily tadalafil at 5 mg has been studied in clinical trials lasting up to two years, and the consistent finding is that it is safe and well tolerated for most men. Cardiovascular event rates in tadalafil-treated patients have matched or fallen below those seen with placebo, and only a small fraction of users stop the drug because of side effects. The picture is more nuanced than a blanket “yes,” though, because kidney function, other medications, and a few rare risks all factor into whether daily use makes sense for a given person.
What the Long-Term Trials Actually Found
Most safety data on daily tadalafil come from studies running 12 weeks to 24 months. A two-year trial in Chinese men with erectile dysfunction tracked both effectiveness and adverse events across the full period. The most common side effects were upper respiratory tract infections and headache, and the pattern at 24 months looked essentially the same as at 12 months, with no new safety signals emerging over time. Nearly half the men had regained normal erectile function scores by the end of two years.
Another study followed men taking daily 5 mg tadalafil for erectile dysfunction and premature ejaculation. It found the treatment was “effective, tolerable, and safe,” with improvements in both erectile function scores and ejaculatory control that persisted even two years after stopping the drug.
These aren’t isolated results. A meta-analysis pooling data from multiple trials of at least 24 weeks found that daily tadalafil produced slightly better erectile function improvements than on-demand dosing, while the on-demand group actually had a higher rate of any treatment-related side effects overall. For individual side effects like headache, back pain, and indigestion, there was no meaningful difference between daily and as-needed use.
Common Side Effects and Why They Happen
The side effects most people notice with daily tadalafil are mild and tend to ease over the first few weeks. Headache and indigestion are the most frequently reported. Back pain and muscle aches also come up more often than with placebo. An analysis of ten placebo-controlled trials found back pain or muscle aches in roughly 8 to 9 percent of men on tadalafil, compared with about 4 percent on placebo. Very few people stopped treatment because of it.
Researchers investigated the muscle-pain issue specifically, looking for signs of inflammation or actual muscle damage using blood markers, PET scans, and MRI. They found nothing abnormal. The pain appears to be a general effect of the drug’s mechanism and resolves on its own, usually within a couple of days.
Nasal congestion, flushing, and mild dizziness round out the common list. Because the drug relaxes smooth muscle in blood vessel walls, a small drop in blood pressure is expected. In healthy men, that drop is modest enough that it doesn’t cause problems on its own.
Cardiovascular Safety
Heart-related concerns are often the first thing people ask about. The evidence here is reassuring. A large pooled analysis of tadalafil clinical studies found that the rate of heart attack among tadalafil users was 0.43 per 100 patient-years, lower than both the placebo group (0.60) and the expected rate in the age-matched male population. Stroke rates were similarly comparable to what would be expected in men of the same age who weren’t taking the drug. Daily dosing at 20 mg for 26 weeks in one trial produced blood pressure changes no different from placebo.
The researchers behind that analysis concluded that the data “suggest that tadalafil can be safely used by healthy subjects and by patients with cardiovascular diseases.” That statement applies to men who are not taking nitrate medications, an important distinction covered below.
The Nitrate Rule
The single most dangerous drug interaction with tadalafil is nitrates, the medications used for chest pain (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate). Both tadalafil and nitrates lower blood pressure through related pathways, and combining them can cause a steep, potentially life-threatening drop. A dedicated timing study found that nitroglycerin given within 24 hours of a tadalafil dose caused standing systolic blood pressure to fall below 85 mm Hg in significantly more subjects than placebo. At 48 hours and beyond, the interaction disappeared.
Because tadalafil’s half-life is long, roughly 17.5 hours, this interaction window stretches further than it does with shorter-acting drugs in the same class. If you use nitrates in any form, daily tadalafil is off the table. This includes recreational use of amyl nitrite (“poppers”). Alpha-blockers used for prostate symptoms also interact, though less dramatically; doctors typically manage this by adjusting the alpha-blocker dose rather than avoiding the combination entirely.
Daily Versus On-Demand Dosing
Tadalafil is unusual among erectile dysfunction drugs in that it was specifically approved for once-daily use at a lower dose (2.5 or 5 mg), separate from the higher on-demand doses (10 or 20 mg taken before sex). One head-to-head comparison found that daily 10 mg tadalafil led to successful intercourse 84 percent of the time, compared with 69 percent for on-demand 20 mg, both far better than the 30 percent baseline. The daily group also showed a larger improvement in erectile function scores.
A trial comparing daily tadalafil, on-demand tadalafil, and on-demand sildenafil found that both tadalafil groups reported greater gains in sexual self-confidence and feelings of spontaneity than the sildenafil group. The actual erectile function improvements were similar across all three arms, but the psychological dimensions favored daily use. For many men, the freedom to not plan around a pill is the biggest practical advantage.
Pharmacokinetic studies help explain why this works. When tadalafil is taken every day, blood levels reach a steady state by about day five, with roughly 1.6-fold accumulation consistent with the drug’s long half-life. That steady background level means the drug is always working, rather than peaking and fading around each dose.
Beyond Erectile Dysfunction
Daily tadalafil at 5 mg is also approved for lower urinary tract symptoms caused by an enlarged prostate, a condition that often overlaps with erectile dysfunction in men over 50. The evidence here is solid across multiple trials. An international placebo-controlled trial found that daily tadalafil improved prostate symptom scores significantly compared with placebo, with the effect becoming apparent within the first week and reaching statistical significance by week four.
A post-marketing surveillance study in Korean men confirmed these findings in a real-world setting. About 69 percent of patients had a clinically meaningful improvement in their symptom scores over 12 to 24 weeks. A review of the BPH literature noted that while tadalafil consistently improves symptom scores and quality of life regardless of whether the patient also has erectile dysfunction, it generally does not improve maximum urine flow rate or the volume of urine left in the bladder after voiding. That distinction matters because it means the drug helps how the symptoms feel more than it changes the underlying obstruction.
A study of men aged 70 and older found that daily tadalafil improved prostate symptom scores, including both voiding and storage subscores, at every time point measured. The improvements were comparable to those seen in younger men, and the drug was well tolerated in this older group.
Kidney and Liver Function
How your kidneys and liver work changes how much tadalafil accumulates in your body, and this is one area where “safe for most people” carries genuine caveats. A pharmacokinetic study found that men with mild to moderate kidney impairment had roughly double the drug exposure of men with healthy kidneys. In men with end-stage kidney disease, a key metabolite accumulated to about three times normal levels, and dialysis barely helped clear it. The study also found that a 10 mg dose was not well tolerated in subjects with moderate kidney dysfunction.
Liver impairment, by contrast, had negligible effects on drug exposure in the same study. This is consistent with tadalafil being primarily cleared by the liver’s CYP3A4 enzyme system; mild liver dysfunction doesn’t bottleneck the process the way kidney trouble does. Still, people with severe liver disease are typically advised to use the drug cautiously or not at all, because long-term data in that population are thin.
Effects on Sperm and Fertility
This is a question that comes up often for younger men considering daily use, and the human evidence is cautiously encouraging. A study in fertile men found that once-daily 5 mg tadalafil led to statistically significant improvements in sperm motility, the percentage of normal-form sperm, and semen volume. Total sperm count also trended upward. No unexpected safety findings were observed.
Animal data tell a different story, however. A study in aging rats given tadalafil daily found time-dependent declines in sperm count and motility, along with structural changes in testicular tissue, including loosely packed connective tissue and reduced numbers of sperm-producing cells. The damage was worse with longer exposure. Rat studies don’t translate directly to humans, and the doses were proportionally higher, but the findings are a reminder that very long-term effects on reproductive tissue haven’t been fully mapped in people. Men actively trying to conceive should discuss this with their doctor, though the available human data lean positive rather than negative.
Rare but Serious Adverse Events
Two rare events associated with all drugs in tadalafil’s class deserve mention. Sudden hearing loss has been reported in a small number of users. A review of the clinical and scientific literature concluded that these drugs are “considered a risk factor for sudden deafness,” though the absolute numbers are very small and a clear causal mechanism hasn’t been established. If you notice sudden hearing changes while taking tadalafil, stop the drug and see a doctor immediately.
Priapism, an erection lasting more than four hours, is another rare but well-known risk with any erectile dysfunction medication. It is more likely in men with conditions that predispose to it, such as sickle cell disease. Daily low-dose tadalafil carries a lower risk than higher on-demand doses, but the possibility exists.
A rare visual disturbance called non-arteritic anterior ischemic optic neuropathy (NAION) has been reported with all PDE5 inhibitors as well. The FDA added warnings about it years ago, though the causal link remains debated. Men who have already had NAION in one eye are generally advised not to use the drug.
Who Stops Taking It and Why
Discontinuation rates offer a practical window into real-world tolerability. A meta-analysis of 44 studies, covering men using daily tadalafil for urinary symptoms with or without erectile dysfunction, found an overall discontinuation rate of about 13 percent. Roughly 5 percent stopped because of side effects, and about 3 percent stopped because the drug wasn’t working well enough for them. Those numbers are relatively low for a daily medication taken indefinitely.
A six-month observational study of men taking daily tadalafil for erectile dysfunction found that about 86 percent were still on the drug at the end of the observation period. The estimated time at which a quarter of men had switched or stopped was around 31 weeks. These figures suggest that the large majority of men who start daily tadalafil find it tolerable enough to continue.
Does the Drug Lose Effectiveness Over Time
Tolerance, where you need higher doses to get the same effect, is a common concern with any daily medication. The available evidence suggests tadalafil does not lose its punch with continued use. The two-year Chinese trial showed that erectile function scores were slightly better at 24 months than at 12 months, not worse. The meta-analysis comparing daily and on-demand tadalafil over at least 24 weeks found sustained benefits in the daily group with no signal of declining efficacy. Quality-of-life scores in multiple BPH studies also held steady or improved across 24-week observation periods.
Emerging Research Areas
Some of the more interesting work on daily tadalafil involves effects well beyond erections or urinary symptoms. A study of men with benign prostatic hyperplasia found that daily tadalafil improved arterial pulse wave velocity, a marker of blood vessel stiffness. The researchers concluded the drug has the potential to improve endothelial function, the ability of blood vessel linings to relax and dilate properly. This is biologically plausible: the enzyme tadalafil inhibits is found throughout the vascular system, not just in pelvic tissue.
A pilot study in men with type 2 diabetes and erectile dysfunction tested whether daily tadalafil might also affect blood sugar control. After six months, the tadalafil group showed a greater reduction in HbA1c (a measure of average blood sugar) and fasting blood glucose compared with placebo. The improvements were modest but statistically significant. The mechanism may involve improved blood flow to the pancreas or enhanced insulin signaling, though this remains speculative. It was a small, single study, and nobody should take tadalafil as a diabetes treatment, but the finding hints that daily PDE5 inhibition may have metabolic benefits worth investigating further.
Tadalafil has also been tested in Raynaud’s phenomenon, a condition where blood vessels in the fingers and toes constrict excessively in response to cold or stress. A double-blind crossover trial in patients with secondary Raynaud’s who hadn’t responded to other vasodilators found that tadalafil significantly reduced the frequency and duration of attacks and improved quality of life and flow-mediated dilation compared with both baseline and placebo. For people with a debilitating vascular condition and few other options, that is a meaningful result.
Pulmonary Arterial Hypertension
At a much higher dose of 40 mg daily, tadalafil is approved for pulmonary arterial hypertension, a serious condition involving high blood pressure in the arteries of the lungs. A landmark trial published in Circulation found that 40 mg daily was well tolerated and improved exercise capacity, quality of life, and clinical worsening outcomes. A review of the evidence in this population confirmed that adverse events at the 40 mg dose were typically mild to moderate, and discontinuation rates remained low. This is relevant context because it shows that even at eight times the standard daily erectile dysfunction dose, the drug’s safety profile holds up reasonably well under close medical supervision. It also underscores that tadalafil is a serious pharmaceutical agent with system-wide vascular effects, not a lifestyle supplement to be taken casually without medical input.